Ivan Kairatov is an esteemed biopharma expert with extensive knowledge in technological innovation within the industry, particularly in research and development. Today, we'll delve into the recent FDA approval of Regeneron's Lynozyfic for multiple myeloma and its implications for patients and
The unforeseen impact of the COVID-19 pandemic initiated a global rush not only to discover vaccines but also to explore effective antiviral drugs capable of counteracting multiple coronaviruses. This effort has evolved beyond traditional scientific methods, incorporating surprising and innovative
The process of drug discovery and development, often stretching over decades, is one of the most demanding and expensive tasks faced by the pharmaceutical industry. Recently, Artificial Intelligence (AI) has emerged as a promising tool to streamline this process, promising dramatic reductions in
The ever-evolving battle against bowel cancer has encountered a formidable challenge: drug resistance. Bowel cancer, one of the most common cancers in the U.K., affects over 44,000 individuals annually, pushing scientists to devise new tools for predicting how this cancer can evolve against
In the rapidly progressing world of biomedical science, imaging technologies play a pivotal role in unlocking the mysteries of human health. Over the last few years, lipid imaging mass spectrometry has emerged as a groundbreaking tool, offering unprecedented insights into the complex nature of
In a groundbreaking advancement in cellular biology, scientists at the University of Virginia School of Medicine and the NIH have uncovered a previously unknown organelle, named the hemifusome. This advancement promises profound impacts on understanding and potentially treating complex genetic
